Skip to main content

Main menu

  • Content
    • Current Issue
    • Advance Access
    • Archive
    • Supplements
    • Topic Collections
  • For Authors
    • Instructions for Authors
    • Submit Manuscript
    • Supplements
  • About
    • About GHSP
    • Editorial Team
    • Editorial Board
    • FAQs
    • Instructions for Reviewers
  • Webinars
    • Local Voices Webinar
    • Connecting Creators and Users of Knowledge
    • Publishing About Programs in GHSP
  • Other Useful Sites
    • GH eLearning
    • GHJournal Search

User menu

  • My Alerts

Search

  • Advanced search
Global Health: Science and Practice
  • Other Useful Sites
    • GH eLearning
    • GHJournal Search
  • My Alerts

Global Health: Science and Practice

Dedicated to what works in global health programs

Advanced Search

  • Content
    • Current Issue
    • Advance Access
    • Archive
    • Supplements
    • Topic Collections
  • For Authors
    • Instructions for Authors
    • Submit Manuscript
    • Supplements
  • About
    • About GHSP
    • Editorial Team
    • Editorial Board
    • FAQs
    • Instructions for Reviewers
  • Webinars
    • Local Voices Webinar
    • Connecting Creators and Users of Knowledge
    • Publishing About Programs in GHSP
  • Alerts
  • Visit GHSP on Facebook
  • Follow GHSP on Twitter
  • RSS
  • Find GHSP on LinkedIn
EDITORIAL
Open Access

COVID-19 Vaccine Hesitancy

Doug Storey
Global Health: Science and Practice February 2022, 10(1):e2200043; https://doi.org/10.9745/GHSP-D-22-00043
Doug Storey
aJohns Hopkins Center for Communication Programs, Baltimore, MD, USA.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: dstorey@jhu.edu
PreviousNext
  • Article
  • Info & Metrics
  • Comments
  • PDF
Loading

See related article by Kulkarni et al.

As access to the coronavirus disease (COVID-19) vaccination expands around the world, attention has turned to the factors that influence vaccine acceptance and hesitancy.1–4 For example, the COVID Behaviors Dashboard (https://covidbehaviors.org/),5 a collaboration between Facebook/META, Johns Hopkins University, Carnegie Mellon University, and the University of Maryland, tracks reasons for vaccine hesitancy in 115 countries around the world.

The percentage of unvaccinated people who simply don’t like vaccines and reject them outright is relatively small—about 14% globally.5 Some people experience structural barriers to vaccination,6 such as eligibility, difficulty making or getting an appointment, difficulty taking time off from work or school or needing childcare to go for vaccination, distance to a vaccination site, and language barriers. Naturally, the challenges people face vary somewhat from country to country and can change over time.

Other common reasons for vaccine hesitancy are psychosocial in nature and more directly amenable to communication efforts to overcome them. These reasons include concern about side effects, uncertainty about vaccine effectiveness, wanting to wait and see if vaccines are safe, and perceived behavioral norms among one’s peers. While these psychosocial factors are common in many places, they are also shaped by local culture and social conditions and must be studied locally to develop tailored approaches to vaccine communication. For example, patterns of social interaction differ resulting in localized normative perceptions, real and perceived risk of COVID-19 transmission vary, and sources of information differ in their trustworthiness. In this issue of GHSP, Kulkarni et al.7 examine the roles that different information sources have in uptake of the third dose of diphtheria-pertussis-tetanus-hepatitis B-Haemophilus influenzae type-b-pentavalent vaccine. Such variations in these factors indicate a need for continued analysis of how people think about vaccines and vaccination and the social influences that affect their decisions about getting vaccinated.

Where and how people get COVID-19 information affects what they think about the disease and how to respond. Formative research to inform COVID-19 vaccination communication efforts should be asking people who have been vaccinated questions such as:

  • What made you decide to get the vaccine?

  • What do you consider to be the benefits of getting vaccinated?

  • Was there anything that made it hard for you to get vaccinated?

  • How did you overcome that challenge?

  • Where did you get the information that helped you make the decision and get vaccinated?

People who have not yet been vaccinated should be asked the following questions:

  • What are some of the reasons you have not been vaccinated yet?

  • How likely do you think it is that you might become infected with COVID-19?

  • How serious do you think it would be if you did become infected with COVID-19?

  • What proportion of your friends and family has been vaccinated?

  • Where do you get information that helps you decide whether to get vaccinated or not?

The COVID-19 pandemic is global and has connected us in ways we have rarely if ever seen before. Although still not universal, rapidly expanding access to mobile technologies in all parts of the world makes it easier to access information and connect with others across time and distance at unprecedented speeds. As a result, we vicariously share experiences (and trauma) with people who are otherwise quite different from us. Sadly, the same technologies can also spread misinformation and enable close-minded echo chambers and discriminatory communities to form and persist.8 People develop attitudes and beliefs through interaction with others and through what they see and hear in the media, increasingly through online and social media, even in more remote parts of the world. Furthermore, they make choices based in part on what they see their peers and other community members doing and on what they perceive to be approved or disapproved by people around them, so the symbolic environment that surrounds them can be very influential.

The COVID Behaviors Dashboard also opens a window on these dynamics of trust and information use. Information sources that are trusted generally exert more persuasive influence over people who rely on them, but trust does not necessarily result in better health outcomes. Trusting in a source that contains misinformation may pose real danger to personal and public health. According to the Dashboard data, patterns of media use and trust vary somewhat from country to country, but globally the sources of information people report relying on the most are government health authorities and journalists. However, those 2 sources differ considerably in terms of reported trustworthiness.5 The least trusted sources of information tend to be journalists, religious leaders, and politicians, while scientists and health experts, including international agencies like the U.S. Centers for Disease Control and Prevention and the World Health Organization, and local health workers and government health authorities, enjoy higher levels of trust. Fortunately, sources that engender low levels of trust tend to have lower levels of exposure, but people who do trust those sources are more susceptible to the misinformation they carry. Communication planners seeking to promulgate accurate information about COVID-19 should carefully analyze the relationship between trustworthiness and exposure to identify the communication channels that are both trusted and reach the greatest numbers of people.

From a public health perspective, managing the symbolic environment to improve access to accurate information, to improve trust in trustworthy information sources, and to counteract misinformation can go a long way toward improving vaccination decision making.

Notes

Peer Reviewed

First published online: February 22, 2022.

Cite this article as: Storey D. COVID-19 vaccine hesitancy. Glob Health Sci Pract. 2022;10(1):e2200043. https://doi.org/10.9745/GHSP-D-22-00043

  • Received: February 2, 2022.
  • Accepted: February 8, 2022.
  • Published: February 28, 2022.
  • © Storey.

This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly cited. To view a copy of the license, visit https://creativecommons.org/licenses/by/4.0/. When linking to this article, please use the following permanent link: https://doi.org/10.9745/GHSP-D-22-00043

REFERENCES

  1. 1.↵
    1. Afolabi AA,
    2. Ilesanmi OS
    . Dealing with vaccine hesitancy in Africa: the prospective COVID-19 vaccine context. Pan Afr Med J. 2021;38. doi:10.11604/pamj.2021.38.3.27401. pmid:33520072
    OpenUrlCrossRefPubMed
  2. 2.
    1. Cooper S,
    2. van Rooyen H,
    3. Wiysonge CS
    . COVID-19 vaccine hesitancy in South Africa: how can we maximize uptake of COVID-19 vaccines? Expert Rev Vaccines. 2021;20(8):921–933. doi:10.1080/14760584.2021.1949291. pmid:34252336
    OpenUrlCrossRefPubMed
  3. 3.
    1. Horiuchi S,
    2. Sakamoto H,
    3. Abe SK,
    4. et al
    . Factors of parental COVID-19 vaccine hesitancy: a cross sectional study in Japan. PLoS One. 2021;16(12): e0261121. doi:10.1371/journal.pone.0261121. pmid:34919580
    OpenUrlCrossRefPubMed
  4. 4.↵
    1. Lee C,
    2. Holroyd TA,
    3. Gur-Arie R,
    4. et al
    . COVID-19 vaccine acceptance among Bangladeshi adults: understanding predictors of vaccine intention to inform vaccine policy. PLoS One. 2021;17(1):e0261929. doi:10.1371/journal.pone.0261929. pmid:35025903
    OpenUrlCrossRefPubMed
  5. 5.↵
    COVID Behaviors Dashboard. Johns Hopkins Center for Communication Programs in collaboration with Facebook Data for Good, Delphi Group at Carnegie Mellon University, University of Maryland Social Data Science Center, Global Outbreak Alert and Response. Network; 2021. Accessed February 1, 2022. https://covidbehaviors.org/
  6. 6.↵
    1. Boisson A,
    2. Goel V,
    3. Yotebieng M,
    4. Parr JB,
    5. Fried B,
    6. Thompson P
    . Implementation approaches for introducing and overcoming barriers to hepatitis B birth-dose vaccine in sub-Saharan Africa. Glob Health Sci Pract. 2022;10(1):e2100277. doi:10.9745/GHSP-D-21-00277
    OpenUrlAbstract/FREE Full Text
  7. 7.↵
    1. Kulkarni S,
    2. Sengeh P,
    3. Eboh V,
    4. et al
    . Role of information sources in vaccination uptake: insights from a cross-sectional household survey in Sierra Leone, 2019. Glob Health Sci Pract. 2022;10(1):e2100237. doi:10.9745/GHSP-D-21-000237
    OpenUrlAbstract/FREE Full Text
  8. 8.↵
    1. Limaye RJ,
    2. Sauer M,
    3. Ali J,
    4. et al
    . Building trust while influencing online COVID-19 content in the social media world. Lancet Digit Health. 2020; 2(6):e277–e278. doi:10.1016/s2589-7500(20)30084-4. pmid:32322814
    OpenUrlCrossRefPubMed
PreviousNext
Back to top

In this issue

Global Health: Science and Practice: 10 (1)
Global Health: Science and Practice
Vol. 10, No. 1
February 28, 2022
  • Table of Contents
  • About the Cover
  • Index by Author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about Global Health: Science and Practice.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
COVID-19 Vaccine Hesitancy
(Your Name) has forwarded a page to you from Global Health: Science and Practice
(Your Name) thought you would like to see this page from the Global Health: Science and Practice web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
COVID-19 Vaccine Hesitancy
Doug Storey
Global Health: Science and Practice Feb 2022, 10 (1) e2200043; DOI: 10.9745/GHSP-D-22-00043

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
COVID-19 Vaccine Hesitancy
Doug Storey
Global Health: Science and Practice Feb 2022, 10 (1) e2200043; DOI: 10.9745/GHSP-D-22-00043
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Statistics from Altmetric.com

Jump to section

  • Article
    • Notes
    • REFERENCES
  • Info & Metrics
  • Comments
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Let’s Make Life Easier for Health Workers, Not More Complicated
  • A Call to Action: Reinvigorating Interest and Investments in Health Infrastructure
Show more EDITORIAL

Similar Articles

Subjects

  • Health Topics
    • Immunization/Vaccines
    • COVID
US AIDJohns Hopkins Center for Communication ProgramsUniversity of Alberta

Follow Us On

  • Twitter
  • Facebook
  • LinkedIn
  • RSS

Articles

  • Current Issue
  • Advance Access Articles
  • Past Issues
  • Topic Collections
  • Most Read Articles
  • Supplements

More Information

  • Submit a Paper
  • Instructions for Authors
  • Instructions for Reviewers
  • GH Journals Database

About

  • About GHSP
  • Editorial Board
  • FAQs
  • Privacy Policy
  • Contact Us

© 2022 Creative Commons Attribution 4.0 International License. ISSN: 2169-575X

Powered by HighWire